Cellectar Biosciences, Inc.’s Post

Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER-WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape: https://bit.ly/3XGT53f #pivotaltrial #clinicalresearch #cloverwam #waldenstrommacrocglobulinemia #iopofosine #marketlandscape #KOLEvent

Our Chief Operations Officer Jarrod Longcor is participating in a panel at #SNMMI2024 and will be able to share Cellectar's journey, including information about iopofosine131. We are so proud to be a part of this year's Society of Nuclear Medicine and Molecular Imaging (SNMMI)'s Annual Meeting and to have Jarrod speak!

Cellectar Biosciences and City of Hope Cancer Center (City of Hope) Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides https://bit.ly/3WZY3Yo #MycosisFungoides #Collaboration #Biopharma

As we head into the long Memorial Day weekend, we honor the brave men and women who made the ultimate sacrifice defending our nation and our freedoms. Take a moment to reflect on their service and remember those who gave their lives for our country. We wish everyone a safe, fun, and meaningful Memorial Day.  #MemorialDay #HonorThem #FreedomIsntFree #MemorialDayWeekend #Veterans

Cellectar Biosciences released its Q1 2024 financial results and corporate update this morning. See the associated presentation and listen to the audio of this morning’s call here: https://lnkd.in/gKiR5XwQ #FinancialResults #Biopharma #Oncology #Q12024 #radiopharmaceuticals #RPTs #Iopofosine

Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update https://bit.ly/3V9MUDn #FinancialResults #Biopharma #Oncology #Q12024

Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day https://bit.ly/3JPP2tt #radiopharmaceuticals #GuggenheimHealthcareTalks2024 #RPTs #Iopofosine #CLR131

Cellectar is so proud of you Kate! #PatientsEU2024 #Waldenstroms #clinicaltrials

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024 https://bit.ly/3JRVekq #ConferenceCall #Waldenstroms #Biopharma #OncologyResearch